glp-1 with hypothyroidism The Thyroid Twist: How Agonists Are Influencing Autoimmune Thyroid Care Dual Glucagon-Like Peptide-1 (GLP-1) and

Key Pharmacokinetic Factors That Influence Weekly Duration and Individual Response Several biomarkers and physiological factors determine whether a patient experiences consistent appetite suppression or noticeable decline mid-week

doi:10.1038/304368a0

GLP-1 receptor agonists (GLP-1RAs) are currently used for treating type-2 diabetes and obesity because of their effects on appetite, food intake, and body weight loss

At the individual level, tailored goals, dietary and weight self-monitoring, and structured problem-solvingsupported by digital tools such as apps or wearablescan enhance adherence and patient engagement